Delivery Order SPE2DR25D2013-SPE2DR26F5RDS
- Not listed
- The Defense Logistics Agency awarded a $7,789.68 delivery order to AmerisourceBergen Drug Corp for Bromfenac Sodium 0.09% eye drops (1.7mL) under a firm fixed-price contract. The award was made on November 24, 2025, with an ultimate completion date of November 25, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 22, 2025, by the Defense Logistics Agency to supply Bromfenac Sodium 0.09% eye drops in 1.7-milliliter units. The contract is valued at $4,516.24 with a firm fixed price structure and an ultimate completion date of October 23, 2025. This award was competitively awarded with no set-aside designation and represents a direct delivery order under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,328.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bromfenac Sodium 0.09% eye drops (1.7 mL) on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7 mL units, with a ceiling value of $1,069.74. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Bromfenac Sodium 0.09% eye drops. This $1,488.72 contract has a performance period through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7ml units, with a ceiling value of $1,873.23. This non-competitive, firm fixed price delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- This $38,872.30 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,562,911,110 units of Bromfenac Sodium 0.09% Eye Drops, 1.7 ml, to be delivered by November 28, 2023. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor, is for the delivery of Bromfenac Sodium 0.09% Eye Drops 1.7ML. The $1,575.92 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of September 5, 2024. The contract is not designated as a set-aside award. AmerisourceBergen, a for-profit organization, holds a significant $999,999,999 Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $1,313.73 from the Defense Logistics Agency (DLA) Troop Support Medical to supply Bromfenac Sodium 0.09% Eye Drops 1.7mL. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 17, 2023. No set-aside designation was used for this award made against an indefinite delivery contract held by Amerisourcebergen Drug Corp to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7mL units, with a contract ceiling value of $9,699.75. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of May 21, 2025. The delivery order is a child contract issued under AmerisourceBergen's...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5RDSDelivery Order
The Defense Logistics Agency awarded a $2,638.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bromfenac Sodium 0.09% eye drops in 1.7 mL quantities, with an ultimate completion date of February 5, 2026. This non-set-aside contract was competitively awarded and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible procurement vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 2/3/26 |